Evaluating Heart Failure After Implantation of Mechanical Circulatory Support Devices
Tóm tắt
The medical community has seen an explosive rise in the utilization of implantable mechanical circulatory support devices for late-stage cardiomyopathy. Care for these complex patients requires a basic understanding of device physiology and potential complications. This review focuses on an algorithm that incorporates a careful clinical history and examination with diagnostic modalities for the evaluation of a patient who is failing therapy with a continuous-flow left ventricular assist device, as well as the general management and optimization of patients implanted with an artificial heart.
Tài liệu tham khảo
• Slaughter MS, Rogers JG, Milano CA, et al. The HeartMate II investigators: advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med. 2009;361:2241–51. This randomized controlled trial established the superiority of continuous-flow LVADS over displacement-pump LVADs.
Miller LW, Pagani FD, Russell SD, et al. The HeartMate II clinical investigators: use of a continuous flow device in patients awaiting heart transplantation. N Engl J Med. 2007;357:885–96.
Copeland JG, Smith RG, Arabia FA, et al. The CardioWest total artificial heart investigators: cardiac replacement with a total artificial heart as a bridge to transplantation. N Engl J Med. 2004;351:859–67.
•• Slaughter MS, Pagani FD, Rogers JG, et al. Clinical management of continuous-flow left ventricular assist devices in advanced heart failure. J Heart Lung Transplant. 2010;29:S1–39. This is a comprehensive resource reviewing patient selection, surgical considerations, and postoperative management of patients after implantation of the HeartMate II LVAD.
Bennett MK, Roberts CA, Dordunoo D, et al. Ideal methodology to assess systemic blood pressure in patients with continuous-flow left ventricular assist devices. J Heart Lung Transplant. 2010;29:593–4.
Vollkron M, Voitl P, Ta J, et al. Suction events during left ventricular support and ventricular arrhythmias. J Heart Lung Transplant. 2007;26:819–25.
Rose AG, Park SJ, Bank AJ, Miller LW. Partial aortic valve fusion induced by left ventricular assist device. Ann Thorac Surg. 2000;70:1270–4.
Mudd JO, Cuda JD, Halushka M, et al. Fusion of aortic valve commissures in patients supported by a continuous axial flow left ventricular assist device. J Heart Lung Transplant. 2008;27:1269–74.
Cowger J, Pagani FD, Haft JW, et al. The development of aortic insufficiency in LVAD supported patients. Circ Heart Fail. 2010;3:668–74.
Pak S, Uriel N, Takayama H, et al. Prevalence of de novo aortic insufficiency during long-term support with left ventricular assist devices. J Heart Lung Transplant. 2010;29:1172–6.
Myers TJ, Bolmers M, Gregoric ID, et al. Assessment of arterial blood pressure during support with an axial flow left ventricular assist device. J Heart Lung Transplant. 2009;28:423–7.
Palardy M, Nohria A, Rivero J, et al. Right ventricular dysfunction during intensive pharmacologic unloading persists after mechanical unloading. J Card Fail. 2010;16:218–24.
Kormos RL, Teuteberg JJ, Pagani FD, et al. Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: incidence, risk factors, and effect on outcomes. J Thorac Cardiovasc Surg. 2010;139:1316–24.
Dang NC, Topkara VK, Mercando M, et al. Right heart failure after left ventricular assist device implantation in patients with chronic congestive heart failure. J Heart Lung Transplant. 2006;25:1–6.
Tedford RJ, Hemnes AR, Russell SD, et al. PDE5A inhibitor treatment of persistent pulmonary hypertension after mechanical circulatory support. Circ Heart Fail. 2008;1:213–9.
Horton SC, Khodaverdian R, Chatelain P, et al. Left ventricular assist device malfunction: an approach to diagnosis by echocardiography. J Am Coll Cardiol. 2005;45:1435–40.
Jaski BE, Miller DA, Hoagland PM, et al. Assessment of recurrent heart failure associated with left ventricular assist device dysfunction. J Heart Lung Transplant. 2005;24:2060–7.
Raman SV, Sahu A, Merchant AZ, et al. Noninvasive assessment of left ventricular assist devices with cardiovascular computed tomography and impact on management. J Heart Lung Transplant. 2010;29:79–85.
Boyle AJ, Russell SD, Teuteberg JJ, et al. Low thromboembolism and pump thrombosis with the HeartMate II left ventricular assist device: analysis of outpatient anti-coagulation. J Heart Lung Transplant. 2009;28:881–7.
Thomas MD, Wood C, Lovett M, et al. Successful treatment of rotary pump thrombus with the glycoprotein IIb/IIIa inhibitor tirofiban. J Heart Lung Transplant. 2008;27:925–7.
Delgado R, Frazier OH, Myers TJ, et al. Direct thrombolytic therapy for intraventricular thrombosis in patients with the Jarvik 2000 left ventricular assist device. J Heart Lung Transplant. 2005;24:231–3.
Arabia FA, Copeland JG, Smith RG, et al. International experience with the CardioWest total artificial heart as a bridge to heart transplantation. Eur J Cardiothorac Surg. 1997;11(Suppl):S5–10.
Stribling W, Shah KB, Gunnerson K, et al. Use of nesiritide and renal function following total artificial heart implantation. J Heart Lung Transplant. 2011;30:S96.
Delgado R, Wadia Y, Kar B, et al. Role of B-type natriuretic peptide and effect of nesiritide after total cardiac replacement with the AbioCor total artificial heart. J Heart Lung Transplant. 2005;24:1166–70.
El-Banayosy A, Arusoglu L, Morshuis M, et al. CardioWest total artificial heart: Bad Oeynhausen experience. Ann Thorac Surg. 2005;80:548–52.
Ensor CR, Cahoon WD, Crouch MA, et al. Antithrombotic therapy for the CardioWest temporary total artificial heart. Tex Heart Inst J. 2010;37:149–58.